Evopraz-DSR Capsule is a combination medication containing Domperidone 30mg and Pantoprazole 40mg, designed to effectively manage gastrointestinal disorders. Domperidone is a prokinetic agent that enhances gastrointestinal motility by blocking dopamine receptors, thereby facilitating faster gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor, works by suppressing gastric acid secretion through irreversible inhibition of the H+/K+ ATPase enzyme system in the gastric parietal cells. This dual-action formulation is particularly beneficial for patients suffering from acid-related conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome, as well as functional dyspepsia. By combining these two active ingredients, Evopraz-DSR Capsule not only alleviates acid reflux and heartburn but also improves gastric motility, offering comprehensive relief from upper gastrointestinal symptoms. It is typically prescribed to be taken orally, once daily before meals, ensuring optimal efficacy. Patients should use this medication under medical supervision, especially those with liver or kidney impairment, and report any adverse effects such as headache, dry mouth, or abdominal cramps. Evopraz-DSR Capsule provides a synergistic approach to managing complex digestive issues, improving patient comfort and quality of life.